BP12 Alexion Pharma UK Company, a division of AstraZeneca, is a leading organization in the field of rare diseases, dedicated to transforming the lives of patients through innovative medicines. With over three decades of experience, the company has pioneered advancements in understanding the complex biology of the complement system, resulting in groundbreaking treatments. Alexion fosters a culture of inclusivity, integrity, and innovation, emphasizing the importance of patient-centricity in its mission. The company values diversity and aims to create an equitable environment where every employee can thrive and contribute to meaningful outcomes for patients and their families.